Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2005, Vol. 105, No. 3, pp. 1003-1009.
Prepublished online as a Blood First Edition Paper on September 28, 2004; DOI 10.1182/blood-2003-11-3997.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-11-3997v1
105/3/1003    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montes de Oca, R.
Right arrow Articles by D'Andrea, A. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montes de Oca, R.
Right arrow Articles by D'Andrea, A. D
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 21, 2003
Accepted September 9, 2004

Regulated interaction of the Fanconi Anemia protein, FANCD2, with chromatin

Rocio Montes de Oca, Paul R Andreassen, Steven P Margossian, Richard G Gregory, Toshiyasu Taniguchi, XiaoZhe Wang, Scott Houghtaling, Markus Grompe, and Alan D D'Andrea*

Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Division of Hematology/Oncology, Children's Hospital of Boston, Boston, MA, USA
Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, OR, USA

* Corresponding author; email: alan_dandrea{at}dfci.harvard.edu.

DNA damage activates the monoubiquitination of the Fanconi Anemia protein, FANCD2, resulting in the assembly of FANCD2 nuclear foci. In the current study, we characterize structural features of FANCD2 required for this intranuclear translocation. We have previously identified two normal mRNA splice variants of FANCD2, one containing exon 44 sequence at the 3' end (FANCD2-44) and one containing exon 43 sequence (FANCD2-43). The two predicted FANCD2 proteins differ in their carboxy terminal 24 amino acids. In stably transfected FANCD2(-/-) fibroblasts, FANCD2-44 and FANCD2-43 proteins were monoubiquitinated on K561. Only FANCD2-44 corrected the MMC sensitivity of the transfected cells. We find that monoubiquitinated FANCD2-44 was translocated from the soluble nuclear compartment into chromatin. A mutant form of FANCD2-44 (FANCD2-K561R) was not monoubiquitinated and failed to bind chromatin. A truncated FANCD2 protein (Exon44-T), lacking the carboxy terminal 24 amino acids encoded by exon 44 but retaining K561, and another mutant FANCD2 protein with a single amino acid substitution at a conserved residue within the C-terminal 24 amino acids (D1428A), were monoubiquitinated. Both mutants were targeted to chromatin but failed to correct MMC sensitivity. Taken together, our results indicate that monoubiquitination of FANCD2 regulates chromatin binding and that D1428 within the carboxy terminal acidic sequence encoded by exon 44 is independently required for functional complementation of FA-D2 cells. We hypothesize that the carboxy terminus of FANCD2-44 plays a critical role in sensing or repairing DNA damage.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
N. Bhagwat, A. L. Olsen, A. T. Wang, K. Hanada, P. Stuckert, R. Kanaar, A. D'Andrea, L. J. Niedernhofer, and P. J. McHugh
XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair
Mol. Cell. Biol., December 15, 2009; 29(24): 6427 - 6437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. G. Howlett, J. A. Harney, M. A. Rego, F. W. Kolling IV, and T. W. Glover
Functional Interaction between the Fanconi Anemia D2 Protein and Proliferating Cell Nuclear Antigen (PCNA) via a Conserved Putative PCNA Interaction Motif
J. Biol. Chem., October 16, 2009; 284(42): 28935 - 28942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Yuan, J. El Hokayem, W. Zhou, and Y. Zhang
FANCI Protein Binds to DNA and Interacts with FANCD2 to Recognize Branched Structures
J. Biol. Chem., September 4, 2009; 284(36): 24443 - 24452.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Q. Fan, F. Zhang, B. Barrett, K. Ren, and P. R. Andreassen
A role for monoubiquitinated FANCD2 at telomeres in ALT cells
Nucleic Acids Res., April 1, 2009; 37(6): 1740 - 1754.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. M. Kim, Y. Kee, A. Gurtan, and A. D. D'Andrea
Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24
Blood, May 15, 2008; 111(10): 5215 - 5222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Hejna, M. Holtorf, J. Hines, L. Mathewson, A. Hemphill, M. Al-Dhalimy, S. B. Olson, and R. E. Moses
Tip60 Is Required for DNA Interstrand Cross-link Repair in the Fanconi Anemia Pathway
J. Biol. Chem., April 11, 2008; 283(15): 9844 - 9851.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Alpi, F. Langevin, G. Mosedale, Y. J. Machida, A. Dutta, and K. J. Patel
UBE2T, the Fanconi Anemia Core Complex, and FANCD2 Are Recruited Independently to Chromatin: a Basis for the Regulation of FANCD2 Monoubiquitination
Mol. Cell. Biol., December 15, 2007; 27(24): 8421 - 8430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Sobeck, S. Stone, and M. E. Hoatlin
DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein FANCD2
Mol. Cell. Biol., June 15, 2007; 27(12): 4283 - 4292.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Kim, J. Chen, and X. Yu
Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response
Science, May 25, 2007; 316(5828): 1202 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Gallmeier and S. E. Kern
Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models
Clin. Cancer Res., January 1, 2007; 13(1): 4 - 10.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. P. H. Ho, S. Margossian, T. Taniguchi, and A. D. D'Andrea
Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance.
Mol. Cell. Biol., September 1, 2006; 26(18): 7005 - 7015.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Barroso, R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas
FANCD2 associated with sporadic breast cancer risk
Carcinogenesis, September 1, 2006; 27(9): 1930 - 1937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kitao, K. Yamamoto, N. Matsushita, M. Ohzeki, M. Ishiai, and M. Takata
Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair
J. Biol. Chem., July 28, 2006; 281(30): 21312 - 21320.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
X. Yu, S. Fu, M. Lai, R. Baer, and J. Chen
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.
Genes & Dev., July 1, 2006; 20(13): 1721 - 1726.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Taniguchi and A. D. D'Andrea
Molecular pathogenesis of Fanconi anemia: recent progress
Blood, June 1, 2006; 107(11): 4223 - 4233.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Sobeck, S. Stone, V. Costanzo, B. de Graaf, T. Reuter, J. de Winter, M. Wallisch, Y. Akkari, S. Olson, W. Wang, et al.
Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks
Mol. Cell. Biol., January 15, 2006; 26(2): 425 - 437.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
S. P. Margossian, G. Ho, R. Kennedy, and A. D. D'Andrea
Functional Interaction between FANCD2 and ATM in the DNA Damage Response.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 181 - 181.
[Abstract]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ishii, T. Inageta, K. Mimori, T. Saito, H. Sasaki, M. Isobe, M. Mori, C. M. Croce, K. Huebner, K. Ozawa, et al.
Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis
PNAS, July 5, 2005; 102(27): 9655 - 9660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-H. Park, S. Margossian, A. A. Horwitz, A. M. Simons, A. D. D'Andrea, and J. D. Parvin
Direct DNA Binding Activity of the Fanconi Anemia D2 Protein
J. Biol. Chem., June 24, 2005; 280(25): 23593 - 23598.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020